Podcasts about Radiosurgery

Join us on the ERCM Medicine Podcast for a conversation with John R. Adler Jr., MD, the visionary inventor of the CyberKnife and founder of Zap-X. As a Stanford professor, Dr. Adler has revolutionized neurosurgery through the development of robotic radiosurgery systems.He shares his extraordinary journey – from being inspired by Lars Leksell at the Karolinska Institute in Stockholm to founding two groundbreaking medical technology companies. He speaks candidly about daily setbacks, the skepticism of colleagues (who initially called the CyberKnife „Adler's Folly“), and why persistence is the key to success.His provocative message to young innovators: „Don't do it – unless you're prepared to never give up.“ This episode provides an honest assessment of the challenges in translating medical innovations into clinical practice.Key Topics:Innovation vs. Reality: Why most inventions failCyberKnife Development: From initial idea to market successRadiosurgery as a surgical tool: Precision without cuttingZapX: The next generation of specialized radiosurgeryMedical resistance: Why some neurosurgeons resist modern technologiesDer ERCM Medizin Podcast – Social & Website:Instagram: @ercm.podcastTikTok: @ercm.podcastWebsite: www.erc-munich.comContact: podcast@erc-munich.comJohn R. Adler Jr., MD:Website: https://zapsurgical.com/About: https://en.wikipedia.org/wiki/John_R._Adler LinkedIn: https://www.linkedin.com/in/john-adler-1875b95/Timestamps:00:00 - Intro02:19 - From Karolinska fellowship to the CyberKnife idea04:46 - The biggest hurdles in the early years06:31 - Persisting despite daily setbacks08:12 - From academic to entrepreneur10:18 - CyberKnife success wasn't enough: The ZapX vision13:37 - Radiosurgery as a neurosurgical tool16:18 - Resistance in the neurosurgery community18:09 - Advice for young innovators: "Don't do it"20:04 - Legacy and unfinished work21:58 - The future of radiosurgery#CyberKnife #Radiosurgery #MedicalInnovation #Neurosurgery #JohnAdler #Entrepreneur #interview #StanfordMedicine #ZapX #ercmpodcast

In an interview with CancerNetwork®, William Kennedy, MD, a neuro-radiation oncologist at the Ivy Brain Tumor Center, provided expert insights into the current state of radiosurgery for central nervous system (CNS) tumors. Highlighting a diverse array of available radiosurgery platforms, he explained that institutions like the Ivy Brain Tumor Center frequently use noninvasive surgical techniques with complex monitoring systems. Kennedy further underscored the critical importance of having a nuanced understanding of each technology's capabilities and limitations, as well as those of the practicing oncologist. Emphasizing a high patient volume and a wide variety of cases at his own practice, he suggested that the expertise of the staff at the Ivy Brain Tumor Center positions them at the forefront of radiosurgery development. According to Kennedy, novel therapeutic strategies under development at Ivy Brain Tumor Center include the investigational agent AZD1390, which is being assessed in combination with radiotherapy after surgery for patients with newly diagnosed or recurrent glioblastoma. Despite the benefits that technology provide for research advancement and treatment, Kennedy posited that the multidisciplinary team is essential in ensuring the successful delivery of novel radiosurgery techniques. This integrated approach ensures that each patient benefits from an individualized plan that leverages the full potential of modern radiosurgery. “[D]espite all the great technologies that we have here at Ivy, what I think makes this place great, what makes me proud to work here, and what means the most for our patients is how closely we providers communicate with each other and how closely knit of a team we are,” Kennedy stated. “Being available, showing up to the tumor board, always picking up the phone when your colleague calls to discuss a tough case, and never being afraid to ask for help—all those things I have learned since I have been in practice here. Those are what make the difference, more than anything.”

This podcast is sponsored by Elekta

This podcast discusses an updated systematic review of the literature and provides new recommendations for the role of Stereotactic Radiosurgery in the treatment of adult patients with Vestibular Schwannoma. Brad Elder, MD Isabelle Germano, MD

In this episode, Drs. Friedman and Bova help listeners understand the radiosurgery paradigm, discuss the kinds of tumors that can be treated with radiosurgery, and explain the role that UF Health has played in the development of radiosurgery.

Stereotactic Radiosurgery for Lung Cancer with guest Dr. Nadine Housri August 27, 2023 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Stereotactic Radiosurgery for Lung Cancer with guest Dr. Nadine Housri August 27, 2023 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Doctors at the Ohio State University Wexner Medical Center and James Cancer Hospital are using functional radiosurgery to treat patients. This is a high-tech method, also called stereotactic radiosurgery, in which extremely precise radiation beams are used to treat a wide range of neurological conditions in a less invasive and more precise way. In this episode, Evan Thomas, MD, a James radiation oncology specialist, and Brian Dalm, MD, a Wexner neurosurgeon explain how they collaborate to reduce the pain of their patients, including many cancer patients, and improve their quality of life. Radiosurgery can be used to target and treat brain tumors. In recent years, improved imaging and a better understanding of the neural networks and pathways in the brain and throughout the body have increased the ways in which this technique is used. Radiosurgery can treat cancerous tumors without traditional surgery that includes an incision. It can also be used to treat tremors and long-term pain by detecting and targeting abnormalities in the neural networks in the body and brain. This origin of the pain can be located anywhere in the body. “We can locate the sensory relay area for the pain in the brain and that can be the target to interrupt the pain network,” Dalm said. “One of the most rewarding things in medicine is knowing you made a difference for a patient,” Thomas said. It can be someone with a tremor so severe “that it prevented them from feeding themselves for years and now they can, or someone with pain so severe they couldn't pick up their grandchild and now they can.”

Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine

Interview with Samuel Ryu, MD, author of Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. Hosted by Jack West, MD. Related Content: Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine

Erin S. Murphy MD is an Associate Professor in the department of radiation oncology at the Cleveland Clinic. She completed residency at the Cleveland Clinic and a fellowship in pediatric radiation oncology at St. Jude Children's Research Hospital. She specializes in radiotherapy and radiosurgery for brain tumors and pediatric tumors and is passionate about using aggressive local tools while maintaining quality of life for her patients. --- What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts - Bereaved Parent Support ✨ Ambassador Agents - Peer Support ✨ Warrior Mail ✨ Young Adult Survivorship Support Group ✨  EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours ✨ RESEARCH: Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 

Title: Radiosurgery versus Surgical Resection for Meningiomas and Schwannomas Guest faculty: Maryam Rahman, MD, MS Moderators: Rushna Ali, MD and Seth F. Oliveria, MD PhD

December 2022 Journal Club Podcast Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery is Well Tolerated in Patients with Melanoma Brain Metastases: An International Multicenter Study of 203 Patients To read the journal article: https://journals.lww.com/neurosurgery/Fulltext/2022/12000/Concurrent_Administration_of_Immune_Checkpoint.7.aspx Lead Author: Eric Lehrer Co-author: Daniel Trifiletti Guest faculty: Toral Patel Moderator: Jeffrey Traylor Committee Co-chair/Planner: Rafael Vega

Practical Radiation Oncology executive editor Sanford Meeks, PhD, hosts a conversation on the use of single-isocenter radiosurgery for multiple metastases. Dr. Meeks is joined by Richard Popple, PhD and John Fiveash, MD from the University of Alabama at Birmingham, as well as Stephen Tenn, PhD from the University of California, Los Angeles and Catherine Mercado, MD, from Orlando Health Cancer Institute. Dr. Meeks and guests discuss the changes in radiosurgery technology, features and differences of different radiosurgery systems, treatment planning procedures, and the clinical considerations when adopting these modalities.

พูดคุยกันเรื่องการรักษาโรคด้วยรังสีอีกครั้ง คราวนี้ไปพูดคุยกับคุณหมอวิน รศ. นพ. พิทยา ด่านกุลชัย หัวหน้าสาขารังสีรักษา ภาควิชารังสีวิทยา คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล ว่ารังสีศัลยกรรม (หรือ Radiosurgery) มันต่างจากการฉายรังสีแบบ 2 มิติ 3 มิติ หรือแบบปรับความเข้ม อย่างไร รวมถึงความเข้มข้นของรังสี และความแม่นยำของการใช้งาน ที่เรียกได้ว่าแตกต่างกันอย่างมาก #SalmonPodcast #โรคภัยใคร่รู้ #ภาพดีทวีสุข #เอกพรศรีสุขทวีรัตน์ #กิติพงศ์สุนทราภา

Gene Barnett, MD, MBA, neurosurgeon and Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center joins the Cancer Advances podcast to discuss the standard of care for brain metastases. Listen as Dr. Barnett discusses how the traditional surgical approaches for treating patients with brain metastases have evolved and how we are using stereotactic radiosurgery to deliver superior outcomes.

Dr. Sharad Goyal, Chief of the GW Radiation Oncology division at the GW Cancer Center, discusses advances in radiosurgery.

Advanced Radiosurgery Techniques with guest Dr. Jethwa Krishan June 27, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Advanced Radiosurgery Techniques with guest Dr. Jethwa Krishan June 27, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Advanced Radiosurgery Techniques with guest Dr. Jethwa Krishan June 27, 2021 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Episode 37 will be about Cyberknife.    To start, Cyberknife® is defined as per below:    CyberKnife® System uses state-of-the-art robotic technology combined with real-time image guidance to deliver precisely-targeted radiation to cancerous and non-cancerous lesions almost anywhere in the body. Real-time tumour tracking enables the delivery of high doses of radiation with sub-millimetre accuracy, sparing surrounding healthy tissue and organs without the need for invasive immobilisation devices.   To know more about this technology, we have invited Peter Podias - the Director of Operations of 5D Clinics, the only private Cyberknife® clinic in Australia.    Peter will discuss how Cyberknife® works, what it does, what diseases it can help, the process, how much it costs, what are its short term and long term effects, and a lot more questions you might also want to know the answers to.   If you're the one who's been looking for a few different options, this episode is surely for you.    This is also for you if you're a sci-fi movie fan because as Melissa says, Cyberknife® is like something that came out from the movies.    It's actually for everyone too who would love to know how much Science has evolved in terms of radiation therapy.    Have a listen at the link below. And don't forget to share this episode with anyone who you feel can benefit from it. Thank you. ;)    Just for a bit of fun, see if you can say: "Peter Podias who is on the phenomenal Penis Project Podcast!” 3 times ------ Thanks for listening. Please subscribe for further episodes either where you listen to your podcasts or on the website www.thepenisproject.org and we would love your feedback.   Websites: https://thepenisproject.org/ https://rshealth.com.au/ http://www.menshealthphysiotherapy.com.au/ http://prost.com.au/ https://www.theyogavine.com.au   Facebook: https://www.facebook.com/Restorativeshealthclinic   Music David Mercy https://open.spotify.com/artist/1HbvnltKu4XbWTmk0kpVB9?si=D1xP5dDVQK-zzNU3rViRWg   Producer Thomas Evans: The SOTA Process https://www.instagram.com/thesotaprocess/ https://player.whooshkaa.com/shows/the-sota-process https://open.spotify.com/show/4Jf2IYXRlgfsiqNARsY8fi

Interview with David R. Raleigh, MD, PhD, and William C. Chen, MD, authors of Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases: A Systematic Review and Meta-analysis

Interview with David R. Raleigh, MD, PhD, and William C. Chen, MD, authors of Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases: A Systematic Review and Meta-analysis

RADIOSURGERY 2-7-21 3PM

RADIOSURGERY 2-6-21 5PM

Featuring: Joseph H. Schwab, MD, Ilya Laufer, MD, Daniel M. Sciubba, MD Disclosures: Laufer, Ilya: Consulting: BrainLab (A), DePuy Synthes (B), Globus (B), Medtronic (C), SpineWave (B). Schwab, Joseph H.: Scientific Advisory Board: Chordoma Foundation (None); Speaking and/or Teaching Arrangements: AO Spine (Travel Expense Reimbursement, Outside 12-Month Requirement), Stryker Spine (B, Outside 12-Month Requirement). Sciubba, Daniel M.: Consulting: Baxter (B), DePuy Synthes (B), Globus (B), Medtronic (C), NuVasive (B), Stryker (C). Key: A: $100-$1,000; B: $1001-$10,000; C: $10,001-$25,000; D: $25,001-$50,000; E: $50,001-$100,000; F: $100,001- $500,000; G: $500,001-$1M; H: $1,000,001- $2.5M; I: $2.5M+